Transtek(SZ:300562) Zheng Quan Ri Bao·2025-10-29 08:04Group 1 - The core viewpoint of the article highlights the financial performance of Guangdong Leksin Medical Electronics Co., Ltd. for the first three quarters of 2025, showing a slight increase in revenue and a significant rise in net profit [2] - The company's total operating revenue for the first three quarters reached 757 million yuan, representing a year-on-year growth of 0.10% [2] - The net profit attributable to the parent company was 65.68 million yuan, reflecting a year-on-year increase of 29.99% [2] Group 2 - In 2025, the company launched several incentive plans, including the stock option incentive plan and two employee shareholding plans, aimed at motivating employees [2] - The assessment period for these incentive plans is set for the fiscal years 2025 and 2026, with performance targets of achieving net profits of 80 million yuan and 100 million yuan for the respective years [2]